Waters Parkerson & Co., LLC Amgen Inc Transaction History

Waters Parkerson & Co., LLC

$1.97 Billion
Q3 2024

A detailed history of Waters Parkerson & Co., LLC transactions in Amgen Inc stock. As of the latest transaction made, Waters Parkerson & Co., LLC holds 3,904 shares of AMGN stock, worth $1.03 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

3,904

Previous 3,904 -0.0%

Holding current value

$1.03 Million

Previous $1.22 Million 3.11%

% of portfolio

0.06%

Previous 0.06%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $127,850 - $144,230	500 Added 14.69%	3,904 $1.12 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $1,071 - $1,266	-5 Reduced 0.15%	3,404 $756,000
Q1 2023 May 02, 2023	BUY	$225.79 - $275.2 $1,128 - $1,376	5 Added 0.15%	3,409 $824,000
Q2 2022 Aug 01, 2022	SELL	$230.71 - $256.74 $34,606 - $38,511	-150 Reduced 4.22%	3,404 $828,000
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $2,850 - $3,153	-13 Reduced 0.36%	3,554 $859,000
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $2,585 - $2,958	13 Added 0.37%	3,567 $802,000
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $2,596 - $3,092	-12 Reduced 0.34%	3,554 $817,000
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $2,815 - $3,131	12 Added 0.34%	3,566 $906,000
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $24,528 - $30,099	-124 Reduced 3.37%	3,554 $838,000
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $27,857 - $33,379	-160 Reduced 4.17%	3,678 $712,000
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $633,045 - $713,580	-3,500 Reduced 47.7%	3,838 $729,000
Q4 2018 Feb 12, 2019	SELL	$178.4 - $208.25 $27,116 - $31,654	-152 Reduced 2.03%	7,338 $1.43 Million
Q3 2017 Nov 13, 2017	SELL	$167.29 - $191.0 $174,316 - $199,022	-1,042 Reduced 12.21%	7,490 $1.4 Million
Q2 2017 Aug 11, 2017	BUY	N/A	8,532	8,532 $1.47 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Waters Parkerson & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waters Parkerson & Co., LLC with notifications on news.

Account

Waters Parkerson & Co., LLC Amgen Inc Transaction History